YME1L1 and acute kidney injury: To further demonstrate the role of SREBP1c/YME1L1 signaling in cisplatin‐induced AKI, we constructed a cisplatin‐induced AKI model using SREBP1c KO mice (Figure S8a, Supporting Information).